| Ad Title: |
Cervical Cancer |
| Study Title: |
GOG-204: Randomized Phase III Trial of Paclitaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix |
| Protocol Number: |
1003-644 |
| Department(s) involved in the Study: |
Gynecology, Obstetrics & Gynecology, Simmons Comprehensive Cancer Center
|
| Purpose of the Study: |
Standard of care for cervical tumor which is not curable by surgery or radiation is chemotherapy using cisplatin. The purpose of this research study is to determine the best chemotherapy drug to be given with cisplatin. |
| Participant Eligibility: |
Patients with primary Stage IVB or recurrent or persistent carcinoma of the cervix. |
| Disease/Condition Under Study: |
Cervical Carcinoma |
| Cancer Related Study: |
Yes
|
| Study Drug(s): |
|
| Study Device(s): |
|
| Study Doctor: |
Dr. David Miller |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Parkland Memorial Hospital
|
Yes
|
|
UT Southwestern University Hospitals St. Paul Building
|
Yes
|
|
UT Southwestern University Hospitals Zale Lipshy Building
|
Yes
|
|
Aston Ambulatory Care Center
|
Yes
|
|
| Contact Phone: |
214_648_6753 |
| Email: |
Paula.Honea@utsouthwestern.edu |
| Other Information: |
This is a Gynecologic Oncology Group sponsored trial. |
| Website Keywords: |
Gyn Oncology, Women's Health
|
| Medical Keywords: |
|
